SLC11A1 upregulation mediates the progression of hepatocellular carcinoma and decreased sensitivity to cisplatin by mediating macrophage M2 polarization
SLC11A1 upregulation mediates the progression of hepatocellular carcinoma and decreased sensitivity to cisplatin by mediating macrophage M2 polarization. // Pathology - Research and Practice. – URL: https://www.sciencedirect.com/science/article/pii/S0344033826003651?dgcid=rss_sd_all
SLC11A1 upregulation mediates the progression of hepatocellular carcinoma and decreased sensitivity to cisplatin by mediating macrophage M2 polarization. Pathology - Research and Practice. https://www.sciencedirect.com/science/article/pii/S0344033826003651?dgcid=rss_sd_all
“SLC11A1 upregulation mediates the progression of hepatocellular carcinoma and decreased sensitivity to cisplatin by mediating macrophage M2 polarization.” Pathology - Research and Practice.
@article{article61486,
title = {SLC11A1 upregulation mediates the progression of hepatocellular carcinoma and decreased sensitivity to cisplatin by mediating macrophage M2 polarization},
journal = {Pathology - Research and Practice},
url = {https://www.sciencedirect.com/science/article/pii/S0344033826003651?dgcid=rss_sd_all}
}
ABSTRACT High‐dimensional flow cytometry measures immune cells at single‐cell resolution, enabling systematic characterization of cell populations at scale. But harnessing this potential requires seamless interoperability between the...
Abstract The intraneuronal accumulation of amyloid‐β (Aβ) is an early pathogenic event in Alzheimer's disease (AD), initiating a pathological cascade that includes synaptic dysfunction, metabolic deficits, and eventual neuronal loss....